FTSE MIB
33.755,20 +122,49 (+0,36%) Dow Jones
37.753,31 -45,66 (-0,12%) Nasdaq
15.683,37 -181,88 (-1,15%) Nikkei 225
38.079,70 +117,90 (+0,31%) Petrolio
82,73 +0,04 (+0,05%) Bitcoin EUR
57.286,66 -2.247,96 (-3,78%)
Ramsay Générale de Santé SA (0OD6.L)
| Chiusura precedente | 0,00 |
| Aperto | 0,00 |
| Denaro | N/D x N/D |
| Lettera | N/D x N/D |
| Min-Max giorno | 0,00 - 0,00 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | 11 |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 0,14 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | N/D |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireRamsay Sante : provisional annual results at end of June 2023
PRESS RELEASE Paris, 23rd August 2023 Provisional annual results at the end of June 2023 Group revenue increased by 9.3% to €4.7bn supported by positive activity volume growth in all geographies and recent acquisitions in the Nordic countries. Revenue growth on a like-for-like basis of 7.0%. Group EBITDA decreased by 5.6% to €621.4m, impacted by lower subsidies, high salary and procurement inflation and staff shortage challenges. Group share of net result after tax of €49.4m or 1.1% of revenue m
- GlobeNewswire
Ramsay Sante : Results at the end of March 2023
PRESS RELEASEParis, 2 May 2023 13.5% total revenues growth for the third quarter of this financial year, up to €1.3bn total revenues, supported by a broad-based good dynamics and recent acquisitions in the Nordics countries. Growth on a like-for-like basis of 10.2%. Continuously playing a leading role in addressing the numerous headwinds impacting the healthcare sector in Europe. For the quarter, EBITDA decreased by €30m leading to €137m and 11.0% margin for this quarter, due to lower subsidies,
